BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Argus Health
Medtronic
Julphar
Fish and Richardson
Cantor Fitzgerald
QuintilesIMS
US Army
Daiichi Sankyo
Mallinckrodt

Generated: January 17, 2018

DrugPatentWatch Database Preview

ALBUTEROL Drug Profile

« Back to Dashboard

Which patents cover Albuterol, and when can generic versions of Albuterol launch?

Albuterol is a drug marketed by Armstrong Pharms, Genpharm, Ivax Sub Teva Pharms, Pliva, Actavis Mid Atlantic, Apotex Inc, Aurobindo Pharma Ltd, Bausch And Lomb, Copley Pharm, Hi Tech Pharma, Landela Pharm, Mylan Speclt, Nephron, Ritedose Corp, Roxane, Sun Pharma Global, Teva Pharms, Watson Labs, Watson Labs Inc, Wockhardt Eu Operatn, Amneal Pharms, G And W Labs Inc, Mova, Teva, Vintage, Vistapharm, Mylan, Am Therap, Dava Pharms Inc, Sandoz, Sun Pharm Industries, Ucb Inc, Warner Chilcott, Cipla Ltd, Sandoz Inc, and Watson Labs Teva. and is included in seventy NDAs.

The generic ingredient in ALBUTEROL is albuterol sulfate; ipratropium bromide. There are thirty-seven drug master file entries for this compound. Seventeen suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the albuterol sulfate; ipratropium bromide profile page.

US Patents and Regulatory Information for ALBUTEROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nephron ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE albuterol sulfate; ipratropium bromide SOLUTION;INHALATION 076749-001 Dec 31, 2007 AN RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan ALBUTEROL SULFATE albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 078092-001 Jan 29, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms ALBUTEROL SULFATE albuterol sulfate SYRUP;ORAL 079241-001 May 12, 2010 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan ALBUTEROL SULFATE albuterol sulfate TABLET;ORAL 072894-001 Jan 17, 1991 AB RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva ALBUTEROL SULFATE albuterol sulfate TABLET;ORAL 072780-001 Jun 25, 1993 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Copley Pharm ALBUTEROL SULFATE albuterol sulfate TABLET;ORAL 072967-001 Nov 22, 1991 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pliva ALBUTEROL SULFATE albuterol sulfate TABLET;ORAL 072316-001 Dec 5, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Industries ALBUTEROL SULFATE albuterol sulfate TABLET;ORAL 072637-001 Dec 5, 1989 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva ALBUTEROL SULFATE albuterol sulfate TABLET;ORAL 072939-001 Mar 30, 1990 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs ALBUTEROL SULFATE albuterol sulfate SOLUTION;INHALATION 077772-002 Sep 25, 2007 AN RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Argus Health
Daiichi Sankyo
McKinsey
Federal Trade Commission
Cantor Fitzgerald
Fuji
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot